文献速递神经肿瘤

颅内脑膜瘤:大型单中心手术系列中复发预后因素的系统分析

Intracranial Meningiomas: A Systematic Analysis of Prognostic Factors for Recurrence in a Large Single Institution Surgical Series.
PubMed 文献 · World Neurosurg · 2018-11-26

该单中心手术系列纳入2000年1月至2015年12月296例I-II级脑膜瘤患者,评估影响局部复发的预后因素;

要点

  • 296例I-II级脑膜瘤中次全切除占58%,其中10%接受辅助放疗。
  • 局部复发87例(29.4%),中位复发时间56个月(范围6-214个月)。
  • 接受手术加辅助放疗的患者无局部复发。

核心结论

  • 作者认为复发率受肿瘤级别、手术切除程度以及未完全切除脑膜瘤使用辅助放疗的影响,与肿瘤级别无关。

研究设计与样本

  • 单中心手术系列,纳入2000年1月至2015年12月接受手术的I-II级脑膜瘤患者296例。
  • 切除程度按Simpson标准定义,二分为全切除与次全切除,次全切除时考虑辅助放疗。
  • 临床结局通过神经系统检查及脑磁共振成像评估,第一年每6个月一次,之后每年一次。

主要发现

  • 女性占65.9%,Karnofsky体能状态评分≥80者占94.6%,I级脑膜瘤占79.4%,诊断时有症状者占91.5%。
  • 次全切除占58%,其中10%接受辅助放疗;90.4%患者神经状态改善或稳定。
  • 中位随访79个月(范围24-214个月),局部复发87例(29.4%),中位复发时间56个月(范围6-214个月)。
  • 接受手术加辅助放疗的患者无局部复发。
  • 中位、2年、5年、10年无进展生存分别为172个月、91.1%、80.7%、67.2%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Meningioma is the most common primary intracranial tumor. Surgical resection is the first choice of treatment, whereas the role of adjuvant radiotherapy (RT) is still unclear. Aim of the study was to evaluate prognostic factors influencing the local recurrence rate. METHODS: Patients who had grade I-II meningiomas and underwent surgery were included in the present study. The extent of surgical resection was defined according to Simpson criteria, and were dichotomized as gross total and subtotal resection (STR). Adjuvant RT was considered in case of STR. Clinical outcome was evaluated by neurological examination and brain magnetic resonance imaging, which was performed every 6 months for the first year and yearly thereafter. RESULTS: From January 2000 to December 2015, 296 patients were analyzed. Most were women (65.9%), with a Karnofsky performance status ≥80 (94.6%), grade I meningioma (79.4%), and symptoms at diagnosis (91.5%). STR was performed in 58%, followed by adjuvant RT in 10%. Improvement or stability of neurological status was obtained in 90.4% of patients. The median follow-up time was 79 months (range, 24-214 months). Local recurrence occurred in 87 (29.4%) patients, at a median time of 56 months (range, 6-214 months). No patients, who underwent surgery plus adjuvant RT, had local relapse. The median, 2-, 5-, 10-year progression-free survival were 172 months, 91.1%, 80.7%, and 67.2%, respectively. On univariate and multivariate analysis factors impacting on progression-free survival were grade, extent of surgical resection, and adjuvant RT in case of STR, regardless of meningioma grade. CONCLUSIONS: Overall, our findings suggest that recurrence rates are influenced by grade, extent of surgical resection, and use of adjuvant RT in not completely resected meningioma, regardless of tumor grade.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Pessina F, Navarria P, Clerici E, et al. Intracranial Meningiomas: A Systematic Analysis of Prognostic Factors for Recurrence in a Large Single Institution Surgical Series. World Neurosurg. 2018. PMID: 30496926. doi:10.1016/j.wneu.2018.11.150

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。